Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity,<i>in vivo</i>degradation and drug release

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

in vitro and in vivo Morphology and Degradation of Chitosan Based Thermosensitive Hydrogel as Drug Release Matrix

Preparation and in Vitro Drug Release of Chitosan-G-mpeg Thermosensitive Hydrogel Drug

Thermosensitive Chitosan Hydrogel for Implantable Drug Delivery: Blending Pva to Mitigate Body Response and Promote Bioavailability

Preparation and Properties of Crosslinked Chitosan Thermosensitive Hydrogel for Injectable Drug Delivery Systems

Thermosensitive hydrogel based on poly(ether-ester anhydride) nanoparticle as drug delivery system: preparation, characterization and biocompatibility.

Injectable Chitosan-Based Hydrogel for Implantable Drug Delivery: Body Response and Induced Variations of Structure and Composition.

Dual ionically crosslinked chitosan–based injectable hydrogel as drug delivery system

Sustained Release of PEG-g-chitosan Complexed DNA from Poly(lactide-Co-glycolide).

Preparation, Characterization and Degradation Characteristics of Polyanhydrides Containing Poly(Ethylene Glycol)

PEG-based thermosensitive and biodegradable hydrogels

Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation.

Variation of in situ Gelling Hydrogel Water Content with the Osmotic Pressure and its Impacts on Drug Release

Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Preparation and performance of chitosan/cyclodextrin-g-glutamic acid thermosensitive hydrogel

Preparation of chitosan/pumpkin polysaccharide hydrogel for potential application in drug delivery and tissue engineering

An injectable thermo-sensitive hydrogel of PNICL-PEG-PNICL block copolymer as a sustained release carrier of EGCG

Nonswelling injectable chitosan hydrogel via UV crosslinking induced hydrophobic effect for minimally invasive tissue engineering